Use of everolimus in de novo renal recipients: initial experience in the Greek population.

Papanikolaou, V; Vrochides, D; Margari, P; Imvrios, G; Papagiannis, A; Giakoustidis, D; Fouzas, I; Antoniadis, N; Ouzounidis, N; Ntinas, A; Vergoulas, G; Miserlis, G; Solonaki, F; Takoudas, D

Papanikolaou, V; Vrochides, D; Margari, P; Imvrios, G; Papagiannis, A; Giakoustidis, D; Fouzas, I; Antoniadis, N; Ouzounidis, N; Ntinas, A; Vergoulas, G; Miserlis, G; Solonaki, F; Takoudas, D.

Affiliation

Papanikolaou V; Organ Transplant Unit, Hippokration General Hospital, Thessaloniki, Hellas. vaspap@med.auth.gr

Transplant Proc ; 40(9): 3166-9, 2008 Nov.

Article in En | MEDLINE | ID: mdl-19010223

Subject(s)

Immunosuppressive Agents/therapeutic use; Kidney Transplantation/immunology; Sirolimus/analogs & derivatives; Adrenal Cortex Hormones/therapeutic use; Antibodies, Monoclonal/therapeutic use; Basiliximab; Creatinine/blood; Cyclosporine/therapeutic use; Drug Therapy, Combination; Everolimus; Follow-Up Studies; Humans; Mycophenolic Acid/analogs & derivatives; Mycophenolic Acid/therapeutic use; Recombinant Fusion Proteins/therapeutic use; Retrospective Studies; Sirolimus/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Sirolimus / Immunosuppressive Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Transplant Proc Year: 2008 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google